The latest prostate cancer news
Prostate cancer linked to bacteria, raising hope of new test and treatment
Rachel Hurst, University of East Anglia; Colin Cooper, University of East Anglia, and Jeremy Clark,…
Browsing: Prostate Cancer
Novel therapeutic agents may reduce the oncogenesis of metastatic prostate cancer
Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and…
AACR 2022: Accounting for genetic factors that cause normal variations in PSA levels may improve the accuracy of prostate cancer detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer could be improved by accounting…
Researchers look to licorice for promising cancer treatments
Licorice is more than a candy people either love or hate — it may play…
Game-changing prostate cancer scan available through Medicare from July 1
The Federal Government has announced Medicare funding of a new whole-body scan for patients with…
FDA approves lutetium Lu 177 vipivotide tetraxetan for metastatic castration-resistant prostate cancer
The Food and Drug Administration have approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto) for the…
Researchers reveal strategies for advanced prostate cancer treatment
In a study published in Cell Reports Medicine, a group of Chinese scientists revealed the oncometabolite…
Adjuvant compared to early salvage therapy post prostatectomy in men with PN1 prostate cancer
Men with microscopic evidence of prostate cancer spreading to their pelvic lymph nodes (LNs) following the…
‘Man Van’ launched to speed up early diagnosis of prostate cancer and improve healthcare access
The ‘Man Van’, an innovative new outreach programme, has been launched today to provide free…
Novel radioligand therapy proven superior for metastatic prostate cancer patients
A novel prostate cancer treatment, 225Ac-PSMA-617 radioligand therapy, has been shown to increase the progression…